Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-21-080984
Filing Date
2021-06-14
Accepted
2021-06-14 20:17:10
Documents
1
Period of Report
2021-06-04

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2119701-8_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm2119701-8_3seq1.xml 3 4143
  Complete submission text file 0001104659-21-080984.txt   5630
Mailing Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036 9732420005
Synaptogenix, Inc. (Issuer) CIK: 0001571934 (see all company filings)

EIN.: 461585656 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O KIRKLAND & ELLIS LLP 300 NORTH LASALLE CHICAGO IL 60654
Business Address
Singer William S. (Reporting) CIK: 0001617927 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40458 | Film No.: 211016351